| 1 | Interrater reliability: the kappa statistic (10.11613/bm.2012.031) | Abstract References ORCID License | 420.62 | 16076 |
| 2 | Understanding Bland Altman analysis (10.11613/bm.2015.015) | Abstract References ORCID License | 354.01 | 3467 |
| 3 | The Chi-square test of independence (10.11613/bm.2013.018) | Abstract References ORCID License | 334.28 | 2201 |
| 4 | Understanding logistic regression analysis (10.11613/bm.2014.003) | Abstract References ORCID License | 302.98 | 1070 |
| 5 | On determining the most appropriate test cut-off value: the… (10.11613/bm.2016.034) | Abstract References ORCID License | 277.23 | 591 |
| 6 | Observational and interventional study design types; an over… (10.11613/bm.2014.022) | Abstract References ORCID License | 268.75 | 486 |
| 7 | Multiple comparison analysis testing in ANOVA (10.11613/bm.2011.029) | Abstract References ORCID License | 262.53 | 421 |
| 8 | The many faces of estrogen signaling (10.11613/bm.2014.035) | Abstract References ORCID License | 254.78 | 352 |
| 9 | Clinical and diagnostic utility of saliva as a non-invasive… (10.11613/bm.2015.018) | Abstract References ORCID License | 243.93 | 274 |
| 10 | Comparison of methods: Passing and Bablok regression (10.11613/bm.2011.010) | Abstract References ORCID License | 242.98 | 268 |
| 11 | Interferences from blood collection tube components on clini… (10.11613/bm.2014.006) | Abstract References ORCID License | 242.65 | 266 |
| 12 | Understanding the effect size and its measures (10.11613/bm.2016.015) | Abstract References ORCID License | 235.98 | 228 |
| 13 | Lipemia: causes, interference mechanisms, detection and mana… (10.11613/bm.2014.008) | Abstract References ORCID License | 233.85 | 217 |
| 14 | Reference intervals: current status, recent developments and… (10.11613/bm.2016.001) | Abstract References ORCID License | 233.85 | 217 |
| 15 | The use of platelet indices, plateletcrit, mean platelet vol… (10.11613/bm.2016.020) | Abstract References ORCID License | 232.84 | 212 |
| 16 | Inflammation and hemostasis (10.11613/bm.2012.006) | Abstract References ORCID License | 222.27 | 166 |
| 17 | The effect of storage time and freeze-thaw cycles on the sta… (10.11613/bm.2013.009) | Abstract References ORCID License | 220.14 | 158 |
| 18 | Bias in research (10.11613/bm.2013.003) | Abstract References ORCID License | 219.87 | 157 |
| 19 | Diabetes and beta cell function: from mechanisms to evaluati… (10.11613/bm.2013.033) | Abstract References ORCID License | 218.75 | 153 |
| 20 | Osteoimmunology and the influence of pro-inflammatory cytoki… (10.11613/bm.2013.007) | Abstract References ORCID License | 218.47 | 152 |
| 21 | Effects of hemolysis interference on routine biochemistry pa… (10.11613/bm.2011.015) | Abstract References ORCID License | 217.61 | 149 |
| 22 | Preanalytical requirements of urinalysis (10.11613/bm.2014.011) | Abstract References ORCID License | 214.61 | 139 |
| 23 | Pathologic patterns of interleukin 10 expression – A review (10.11613/bm.2015.004) | Abstract References ORCID License | 214.30 | 138 |
| 24 | Comparing groups for statistical differences: how to choose… (10.11613/bm.2010.004) | Abstract References ORCID License | 210.04 | 125 |
| 25 | The odds ratio: calculation, usage, and interpretation (10.11613/bm.2009.011) | Abstract References ORCID License | 208.99 | 122 |
| 26 | Molecular pathways in cancer-related inflammation (10.11613/bm.2011.036) | Abstract References ORCID License | 207.55 | 118 |
| 27 | Uric acid as one of the important factors in multifactorial… (10.11613/bm.2012.007) | Abstract References ORCID License | 206.82 | 116 |
| 28 | Altmetrics – a complement to conventional metrics (10.11613/bm.2015.016) | Abstract References ORCID License | 206.45 | 115 |
| 29 | Copeptin and its potential role in diagnosis and prognosis o… (10.11613/bm.2013.021) | Abstract References ORCID License | 206.07 | 114 |
| 30 | Preanalytical phase – a continuous challenge for laboratory… (10.11613/bm.2012.017) | Abstract References ORCID License | 203.34 | 107 |
| 31 | The paraoxonase 1, 2 and 3 in humans (10.11613/bm.2011.020) | Abstract References ORCID License | 201.28 | 102 |
| 32 | Dealing with the positive publication bias: Why you should r… (10.11613/bm.2017.030201) | Abstract ORCID License | 196.20 | 412 |
| 33 | What we need to know when calculating the coefficient of cor… (10.11613/bm.2007.002) | Abstract References ORCID License | 193.45 | 85 |
| 34 | Aberrant methylation patterns in cancer: a clinical view (10.11613/bm.2015.017) | Abstract References ORCID License | 193.45 | 85 |
| 35 | Capillary blood sampling: national recommendations on behalf… (10.11613/bm.2015.034) | Abstract References ORCID License | 191.38 | 81 |
| 36 | Serological markers of inflammatory bowel disease (10.11613/bm.2013.006) | Abstract References ORCID License | 188.08 | 75 |
| 37 | Harmonization of pre-analytical quality indicators (10.11613/bm.2014.012) | Abstract References ORCID License | 188.08 | 75 |
| 38 | Iron metabolism: current facts and future decisions (10.11613/bm.2012.034) | Abstract References ORCID License | 186.92 | 73 |
| 39 | Phlebotomy, a bridge between laboratory and patient (10.11613/bm.2016.002) | Abstract References ORCID License | 185.13 | 70 |
| 40 | Preanalytical considerations in blood gas analysis (10.11613/bm.2013.005) | Abstract References ORCID License | 184.51 | 69 |
| 41 | Increased plasma zonulin in patients with sepsis (10.11613/bm.2013.013) | Abstract References ORCID License | 184.51 | 69 |
| 42 | The laboratory test utilization management toolbox (10.11613/bm.2014.025) | Abstract References ORCID License | 183.88 | 68 |
| 43 | Salami publication: definitions and examples (10.11613/bm.2013.030) | Abstract References ORCID License | 183.25 | 67 |
| 44 | Stability studies of common biochemical analytes in serum se… (10.11613/bm.2012.023) | Abstract References ORCID License | 182.61 | 66 |
| 45 | The misuse and abuse of statistics in biomedical research (10.11613/bm.2015.001) | Abstract References ORCID License | 182.61 | 66 |
| 46 | Specimen rejection in laboratory medicine: Necessary for pat… (10.11613/bm.2015.037) | Abstract References ORCID License | 182.61 | 66 |
| 47 | Hemolysis detection and management of hemolysed specimens (10.11613/bm.2010.018) | Abstract References ORCID License | 179.24 | 61 |
| 48 | Croatian Society of Medical Biochemistry and Laboratory Medi… (10.11613/bm.2013.031) | Abstract References ORCID License | 178.53 | 60 |
| 49 | Neutrophil CD64 as a sepsis biomarker (10.11613/bm.2011.038) | Abstract References ORCID License | 177.82 | 59 |
| 50 | Interferences in quantitative immunochemical methods (10.11613/bm.2009.005) | Abstract References ORCID License | 177.09 | 58 |